Skip to main content
Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: Results from the RELAX-AHF trial
Published Web Location
http://europepmc.org/articles/PMC3992428?pdf=renderNo data is associated with this publication.
Abstract
Aims Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF). Many AHF patients have preserved ejection fraction (HFpEF). Given the lack of evidence-based therapies in this population, we evaluated the effe
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.